News
Even with sprays, irrigations and pills, a staggering 80% of people can't find relief. Now, there's a potentially ...
TipRanks on MSN3d
MannKind Corporation’s Phase 3 Study: A Potential Game-Changer for Nontuberculous Mycobacterial Infections
MannKind Corporation (($MNKD)) announced an update on their ongoing clinical study. Study Overview: MannKind Corporation is conducting a Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback